Free Trial

Albemarle (ALB) Competitors

$127.59
+4.64 (+3.77%)
(As of 05/24/2024 ET)

ALB vs. EMN, AVNT, DD, DOW, GFI, BG, IP, CF, WRK, and SQM

Should you be buying Albemarle stock or one of its competitors? The main competitors of Albemarle include Eastman Chemical (EMN), Avient (AVNT), DuPont de Nemours (DD), DOW (DOW), Gold Fields (GFI), Bunge Global (BG), International Paper (IP), CF Industries (CF), WestRock (WRK), and Sociedad Química y Minera de Chile (SQM). These companies are all part of the "basic materials" sector.

Albemarle vs.

Eastman Chemical (NYSE:EMN) and Albemarle (NYSE:ALB) are both large-cap basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, valuation, earnings, dividends, media sentiment, community ranking and profitability.

In the previous week, Albemarle had 2 more articles in the media than Eastman Chemical. MarketBeat recorded 16 mentions for Albemarle and 14 mentions for Eastman Chemical. Albemarle's average media sentiment score of 0.78 beat Eastman Chemical's score of 0.52 indicating that Eastman Chemical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Eastman Chemical
6 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Albemarle
8 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Eastman Chemical presently has a consensus target price of $106.24, suggesting a potential upside of 5.98%. Albemarle has a consensus target price of $165.16, suggesting a potential upside of 29.44%. Given Eastman Chemical's higher probable upside, analysts clearly believe Albemarle is more favorable than Eastman Chemical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Eastman Chemical
0 Sell rating(s)
6 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.63
Albemarle
2 Sell rating(s)
8 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.37

Eastman Chemical has a beta of 1.54, indicating that its share price is 54% more volatile than the S&P 500. Comparatively, Albemarle has a beta of 1.65, indicating that its share price is 65% more volatile than the S&P 500.

Eastman Chemical pays an annual dividend of $3.24 per share and has a dividend yield of 3.2%. Albemarle pays an annual dividend of $1.60 per share and has a dividend yield of 1.3%. Eastman Chemical pays out 41.8% of its earnings in the form of a dividend. Albemarle pays out 58.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Eastman Chemical has increased its dividend for 14 consecutive years and Albemarle has increased its dividend for 29 consecutive years. Eastman Chemical is clearly the better dividend stock, given its higher yield and lower payout ratio.

Eastman Chemical has a net margin of 10.16% compared to Eastman Chemical's net margin of 4.02%. Eastman Chemical's return on equity of 14.53% beat Albemarle's return on equity.

Company Net Margins Return on Equity Return on Assets
Eastman Chemical10.16% 13.84% 5.16%
Albemarle 4.02%14.53%7.62%

83.7% of Eastman Chemical shares are owned by institutional investors. Comparatively, 92.9% of Albemarle shares are owned by institutional investors. 1.9% of Eastman Chemical shares are owned by company insiders. Comparatively, 0.4% of Albemarle shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Albemarle has lower revenue, but higher earnings than Eastman Chemical. Eastman Chemical is trading at a lower price-to-earnings ratio than Albemarle, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Eastman Chemical$9.21B1.28$894M$7.7612.92
Albemarle$8.40B1.79$1.57B$2.7546.40

Albemarle received 54 more outperform votes than Eastman Chemical when rated by MarketBeat users. However, 64.48% of users gave Eastman Chemical an outperform vote while only 63.39% of users gave Albemarle an outperform vote.

CompanyUnderperformOutperform
Eastman ChemicalOutperform Votes
708
64.48%
Underperform Votes
390
35.52%
AlbemarleOutperform Votes
762
63.39%
Underperform Votes
440
36.61%

Summary

Albemarle beats Eastman Chemical on 11 of the 21 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ALB vs. The Competition

MetricAlbemarlePlastics materials & resins IndustryMaterials SectorNYSE Exchange
Market Cap$14.45B$10.40B$2.93B$17.75B
Dividend Yield1.23%2.31%5.12%3.52%
P/E Ratio46.4091.06139.4022.58
Price / Sales1.791.59840,257.6310.30
Price / Cash4.8710.8623.7219.42
Price / Book1.571.814.055.92
Net Income$1.57B$234.47M$166.46M$976.87M
7 Day Performance-2.69%-3.10%-0.68%-1.55%
1 Month Performance10.99%7.28%4.57%3.70%
1 Year Performance-37.75%-16.97%18.28%24.45%

Albemarle Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EMN
Eastman Chemical
4.7224 of 5 stars
$99.95
-0.7%
$104.18
+4.2%
+23.4%$11.76B$9.21B12.8814,000Analyst Upgrade
AVNT
Avient
3.9388 of 5 stars
$45.57
0.0%
$46.20
+1.4%
+16.8%$4.16B$3.13B39.639,300Positive News
DD
DuPont de Nemours
4.7504 of 5 stars
$79.52
-0.4%
$82.10
+3.2%
+22.4%$33.25B$11.98B96.9824,000Analyst Forecast
Options Volume
Analyst Revision
News Coverage
DOW
DOW
4.2073 of 5 stars
$58.91
-0.6%
$59.18
+0.5%
+12.6%$41.66B$43.54B35.0735,900
GFI
Gold Fields
1.7165 of 5 stars
$16.55
-1.5%
$13.67
-17.4%
+8.9%$14.81B$4.50B0.006,297Analyst Forecast
BG
Bunge Global
4.3806 of 5 stars
$103.33
+1.0%
$121.00
+17.1%
+14.7%$14.63B$59.54B8.3223,000Insider Selling
IP
International Paper
4.646 of 5 stars
$41.87
+1.7%
$38.57
-7.9%
+44.5%$14.54B$18.92B85.4539,000Analyst Upgrade
Options Volume
Analyst Revision
News Coverage
Gap Up
CF
CF Industries
4.2324 of 5 stars
$78.58
+0.0%
$85.00
+8.2%
+17.9%$14.36B$6.09B13.052,700Positive News
WRK
WestRock
4.2435 of 5 stars
$52.73
+0.5%
$47.60
-9.7%
+93.7%$13.55B$20.31B44.3156,100Positive News
SQM
Sociedad Química y Minera de Chile
4.1383 of 5 stars
$47.31
-3.3%
$65.18
+37.8%
-28.4%$13.51B$7.47B6.717,682Analyst Forecast
News Coverage

Related Companies and Tools

This page (NYSE:ALB) was last updated on 5/25/2024 by MarketBeat.com Staff

From Our Partners